chr10-84232439-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_015613.3(LRIT1):āc.1360A>Gā(p.Lys454Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000156 in 1,614,056 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015613.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRIT1 | NM_015613.3 | c.1360A>G | p.Lys454Glu | missense_variant | 4/4 | ENST00000372105.4 | |
LRIT1 | XM_011539626.3 | c.775A>G | p.Lys259Glu | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRIT1 | ENST00000372105.4 | c.1360A>G | p.Lys454Glu | missense_variant | 4/4 | 1 | NM_015613.3 | P1 | |
RGR | ENST00000652073.1 | c.-495T>C | 5_prime_UTR_variant | 2/8 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251398Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135904
GnomAD4 exome AF: 0.000158 AC: 231AN: 1461848Hom.: 1 Cov.: 32 AF XY: 0.000155 AC XY: 113AN XY: 727242
GnomAD4 genome AF: 0.000131 AC: 20AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2022 | The c.1360A>G (p.K454E) alteration is located in exon 4 (coding exon 4) of the LRIT1 gene. This alteration results from a A to G substitution at nucleotide position 1360, causing the lysine (K) at amino acid position 454 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at